Repligen Corporation (RGEN) vs Teleflex Incorporated (TFX)

Repligen Corporation and Teleflex Incorporated are both Medical Instruments & Supplies companies. Repligen Corporation is the larger, with a market value of $11.7B against $5.4B — 2.2× the size. Teleflex Incorporated has negative trailing earnings, so its P/E is not meaningful; Repligen Corporation trades at 234×. Teleflex Incorporated grew revenue faster over the last twelve months: 110.9% against 16.5%. Repligen Corporation has the higher net margin (5.29% vs −45.8%) and the higher return on invested capital (2.18% vs 0.51%). Across the 21 metrics below, Repligen Corporation leads on 12 and Teleflex Incorporated on 9.

Valuation

Metric RGEN TFX Medical Instruments & Supplies median
P/E 233.60 n/m 33.75
P/S 12.59 2.52 2.52
P/B 4.68 1.96 2.48
Price to free cash flow 161.81 33.74 25.19
EV/EBITDA 60.20 31.97 14.62
EV/Sales 12.35 3.63 2.88
Earnings yield 0.43% (17.85%) (2.67%)
Free cash flow yield 0.62% 2.96% 0.09%

Profitability

Metric RGEN TFX Medical Instruments & Supplies median
Gross margin 53.52% 54.94% 54.29%
Operating margin 8.23% 1.97% 1.07%
Net margin 5.29% (45.76%) (1.61%)
Free cash flow margin 14.06% 7.47% 1.08%
Return on equity 1.99% (28.87%) (1.32%)
Return on assets 1.42% (14.57%) 0.00%
Return on invested capital 2.18% 0.51% 0.00%

Growth

Metric RGEN TFX Medical Instruments & Supplies median
Revenue growth (TTM) 16.49% 110.94% 8.85%
EPS growth (last fiscal year) 286.96% (1,468.24%) 8.65%
Revenue growth, 5-year CAGR 15.05% (4.72%) 9.17%
Net income growth, 5-year CAGR (3.99%) 0.00% 0.00%

Health

Metric RGEN TFX Medical Instruments & Supplies median
Debt to equity 0.26 0.97 0.10
Current ratio 9.05 2.60 2.48
Net debt to EBITDA (1.50) 7.52 0.89

Dividend

Metric RGEN TFX Medical Instruments & Supplies median
Dividend yield — 1.04% 1.11%
Payout ratio — — 0.27

Size

Metric RGEN TFX Medical Instruments & Supplies median
Market cap 11.69b 5.43b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack